In a 2Firsts interview, GFN co-founder Paddy Costall highlighted that entrenched hostility toward industry voices has hindered progress in harm reduction. He urged a return to inclusive dialogue and science-driven strategies to improve public health.

At the GFN 2025, representatives from the world’s four largest tobacco companies emphasized the need for science-driven harm reduction policies. They urged regulators to move beyond outdated approaches and adopt consumer-focused, evidence-based frameworks to better serve public health goals.

At the 2025 Global Forum on Nicotine in Warsaw, experts warned that misinformation about nicotine and safer alternatives is misleading the public and healthcare professionals, hindering smokers’ access to life-saving products.

As part of its GFN media partnership, 2Firsts spoke with FCTC expert Jeannie Cameron, who warns that the WHO’s rejection of harm reduction is leading global tobacco control efforts off course.

Ahead of the upcoming Global Forum on Nicotine (GFN), 2Firsts interviews Nancy Loucas, Executive Coordinator of CAPHRA, on why consumers must have a voice in tobacco harm reduction policymaking—and how she’s helping them speak up.